Long-Term Liabilities: The sum of all non-current liabilities.
Adicet Bio, Inc. (ACET) had Long-Term Liabilities of $12.52M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-31.22M |
|
-- |
|
-- |
|
$32.39M |
|
$-32.39M |
|
$1.18M |
|
$-31.22M |
|
$-31.22M |
|
$-31.22M |
|
$-31.22M |
|
$-31.22M |
|
$-31.22M |
|
$-32.39M |
|
$-31.70M |
|
91.09M |
|
91.09M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$127.74M |
|
$19.55M |
|
$35.23M |
|
$162.97M |
|
$17.08M |
|
-- |
|
|
Long-Term Liabilities |
$12.52M |
$29.60M |
|
$133.37M |
|
$133.37M |
|
$133.37M |
|
83.25M |
|
| Cash Flow Statement Financials | |
$-52.03M |
|
$30.09M |
|
$0.16M |
|
$59.40M |
|
$37.62M |
|
$-21.77M |
|
$6.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-53.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.41% |
|
-23.41% |
|
-19.15% |
|
-23.41% |
|
$1.60 |
|
$-0.59 |
|
$-0.57 |
|